StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.32−0.13 (-8.97%)

Close on Nov 20, 2026Market cap $469.34MP/E –Yield –

Evotec net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2022 it was -€175.66M, down 181.5% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2022Dec 31, 2022-€175.66M-181.5%
FY2021Dec 31, 2021€215.51M+3332.8%
FY2020Dec 31, 2020€6.28M-83.5%
FY2019Dec 31, 2019€38.16M–

More Evotec figures

See a number that looks wrong?